NDTDI

NDTDI
Legal status
Legal status	Illegal in Latvia;
Identifiers
	IUPAC name N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide;
JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23;

NDTDI is a tricyclic

serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.^[1]

Legality

NDTDI was made illegal in Latvia in March 2017.[2]

References

[1] Analytical Report: NDTDI. Nacionalni Forenzični Laboratorij, Slovenia, June 2017

[2] Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.

[1]

Legality

See also

References